Aggregation of alanine-expanded PABPN1 is a hallmark of OPMD and genetic or pharmacological improvement of muscle function often correlates with reduced aggregation load [29,31,32,69], with some exceptions [33,34]. The gene discussed is PABPN1; the disease is oculopharyngeal muscular dystrophy.